Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
about
Halogenation generates effective modulators of amyloid-Beta aggregation and neurotoxicity.Aggregation of detergent-insoluble tau is involved in neuronal loss but not in synaptic lossThe role of hippocampal tau protein phosphorylation in isoflurane-induced cognitive dysfunction in transgenic APP695 mice.Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease.Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease.A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studiesDrosophila models of neurodegenerative diseases.Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.Phospho-dependent ubiquitination and degradation of PAR-1 regulates synaptic morphology and tau-mediated Aβ toxicity in Drosophila.DAPK activates MARK1/2 to regulate microtubule assembly, neuronal differentiation, and tau toxicity.A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spinesSmall-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease ModelsSoluble aβ promotes wild-type tau pathology in vivo.Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.Modeling Alzheimer's disease: from past to futureBrain oligomeric β-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein/tau transgenic mice.Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains.Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease.Role of DAPK in neuronal cell death.Insulin dysfunction and Tau pathology.Invited review: Animal models of tauopathies and their implications for research/translation into the clinic.Enhanced Tau Aggregation in the Presence of Amyloid β.Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalitiesActivation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model.Deconstructing GSK-3: The Fine Regulation of Its Activity.Drosophila melanogaster: Deciphering Alzheimer’s Disease.Drosophila melanogaster: Deciphering Alzheimer's Disease.
P2860
Q28487382-F3CDBD68-62C7-4435-A42E-DD8C53357E30Q30497471-C2CC0727-C225-431F-BDB9-A6E067549C55Q30596714-8CC04F98-A384-4DFC-8C4A-921EED817D36Q33687072-DE5C03D4-6482-4876-8608-F33A31BE1B07Q33980306-11495D0F-4EEC-4FB5-8960-5A877FFC7BF1Q34162478-5F87523C-1AB8-454B-A47D-FC1458A48CE7Q34219001-CA9F9228-72E1-4789-9904-42D3B9EBF754Q34610331-6158CED0-ED20-4F6C-8B0F-86C712A60D3FQ34629320-9C6CD6A0-246A-4575-9EB4-69C3ECD6A666Q35018751-89423939-E08D-476F-ACA4-CE466AAE922EQ35227449-555CFACB-87A8-4B65-8648-A49F93AC05A7Q35771017-077E28CE-8ADB-4DE0-A001-9D86DAA2EC16Q36128825-561CE406-9523-451D-89AD-D1F95D06F224Q36650435-A2A4C819-B03B-402C-8675-534E079E9EC7Q36855702-12E992C6-C2B9-4A22-85E7-5796C8A161DFQ36938165-52080DD8-C68A-413D-9B81-0F4A6596AE0EQ37051783-D4C4EC66-BC4E-4D33-9E4C-4966AB457D4BQ37432185-2A76A254-DF3D-45CC-BC3E-4C614395B1F2Q37630546-158F433B-EFD0-4A25-B568-3E3F4E2564CBQ38151519-403A86F1-49B7-45E9-99BE-FD1AA1949323Q38191590-A870EF05-A714-4FFE-872F-5C40F16021AEQ38271896-12538F56-AD1C-4ADD-9521-2823050C28DDQ38788206-85154A35-F2A5-473F-AF42-DB0A2CF22B9EQ39734068-F9F21C9F-635A-400B-98C3-FC50BD463D94Q41574477-0B4C1F96-59BC-445B-A2D4-6CA9662AF033Q41966030-0B300A85-0182-4104-B070-371DD1A95D45Q42135408-C245C62C-20FB-4FE1-BD18-5114F605F6ADQ47144664-EF3137AD-62DC-4C34-BB4D-F1494D2B2905Q50145050-56CE6057-4306-4EFA-981A-D861F3B70E7D
P2860
Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Characterization of a double ( ...... osphorylation and aggregation.
@en
Characterization of a double
@nl
type
label
Characterization of a double ( ...... osphorylation and aggregation.
@en
Characterization of a double
@nl
prefLabel
Characterization of a double ( ...... osphorylation and aggregation.
@en
Characterization of a double
@nl
P2093
P1433
P1476
Characterization of a double ( ...... osphorylation and aggregation.
@en
P2093
M T G Isla
P Gómez Ramos
P304
P356
10.1016/J.NEUROSCIENCE.2004.09.029
P407
P50
P577
2005-01-01T00:00:00Z